Anadolu Medical Center
| Turquia | Áustria | Espanha | |
| Terapia de radiação para o cancro colorretal | de $7,000 | de $12,000 | de $10,000 |
| Quimioterapia para cancro da mama | de $1,200 | de $15,000 | de $3,500 |
O médico é um oncologista médico turco altamente experiente, especializado em sarcoma, linfoma, câncer de pâncreas, pulmão e mama. Com mais de 20 anos de experiência, o médico foca na biologia tumoral, imunologia tumoral, imunoterapia do câncer e terapias direcionadas. Desde 2019, o médico atua como oncologista médico no Centro Médico Anadolu e anteriormente ocupou cargos de liderança na Faculdade de Medicina da Universidade Okan de Istambul e no Hospital de Treinamento GATA Haydarpaşa. O médico é autor de mais de 40 publicações em pesquisa sobre câncer e é membro da Associação Turca de Oncologia Médica e da Sociedade Europeia de Cabeça e Pescoço.<\/p>
Especialização no Instituto do Cancro da Universidade de Hacettepe – o Dr. Solak é especialista no tratamento de vários tipos de cancros, incluindo cancros do fígado, do pulmão e gastrointestinais, no Hospital Intercontinental Hisar.
A Dra. Eda Tanrikulu está entre os principais oncologistas da Turquia, com experiência especializada em oncologia médica e quimioterapia no Anadolu Medical Center.
Mais de 200 cirurgias hepáticas realizadas – O Prof. Peker é especialista em Cirurgia Hepatopancreatobiliar no Hospital Hisar Intercontinental.
Top Turkish hospitals for stage 3 liver cancer include Anadolu Medical Center, Memorial Şişli, and Medipol Mega University Hospital. These JCI-accredited centers specialize in multidisciplinary care. They utilize advanced technologies like CyberKnife and robotic surgery. Expert teams often achieve 90% success rates in complex liver procedures.
Bookimed Expert Insight: Patient volume is a reliable proxy for expertise in Turkey. Medipol Mega and Hisar Intercontinental handle a combined 1,500,000+ patients annually. This high frequency allows surgeons like Dr. Kivanc Derya Peker to perform over 200 liver surgeries. High-volume centers typically manage stage 3 complications more effectively.
Patient Consensus: Patients emphasize finding hospitals with dedicated tumor boards for individualized planning. They also note that fast access to biopsies and imaging is crucial for advanced cases.
Turkey offers multidisciplinary treatments for stage 3 liver cancer including targeted therapies like TACE and radioembolization. JCI-accredited centers in Istanbul specialize in liver transplantation and advanced surgical resection. These facilities utilize MR Linac and da Vinci robotics to treat complex tumors while preserving healthy liver tissue.
Bookimed Expert Insight: Data shows a clear distinction between academic and private oncology centers. Top-ranked clinics like Anadolu Medical Center maintain affiliations with Johns Hopkins Hospital. This allows patients to access US-standard tumor board reviews. These multidisciplinary teams often re-evaluate patients initially told they were ineligible for surgery.
Patient Consensus: Patients emphasize the need for a second opinion regarding surgical eligibility. Many note that preparing complete imaging and liver-function tests before the first consultation significantly speeds up treatment planning.
Turkey is a leading destination for liver cancer treatment due to high-volume JCI-accredited centers and specialized oncology teams. Facilities like Anadolu Medical Center provide multidisciplinary care through affiliations with Johns Hopkins. Patients benefit from rapid staging using AI-supported 3 Tesla MRI and digital PET/CT imaging.
Bookimed Expert Insight: Data shows that the most successful outcomes for stage 3 cases come from clinics like Istanbul Florence Nightingale, which provides specialized imaging like 512-slice CT. While many focus on surgery, the integration of interventional oncology certifications and high-capacity intensive care units at centers like Memorial Şişli is what often determines long-term success for advanced cases.
Patient Consensus: Patients value the speed of staging and multidisciplinary reviews, though many emphasize the importance of securing a clear local follow-up plan before returning home. They often suggest verifying if the hospital has a dedicated liver tumor board for complex stage 3 planning.
Turkish oncology centers report a 90% to 93.5% 1-year success rate for liver transplants in advanced cases. Specialized procedures for stage 3 liver cancer maintain a 90% success rate. These outcomes rely on JCI-accredited facilities using robotic surgery and precise radioembolization techniques.
Bookimed Expert Insight: Success in stage 3 cases often hinges on multidisciplinary volume rather than just technology. Memorial Sisli Hospital maintains a 90% organ transplant success rate while serving patients from 167 countries. This high international volume ensures surgeons are exceptionally experienced with the complex vascular involvement common in stage 3 tumors. Choosing a center with ISO and JCI certifications provides a verified safety net for these intricate procedures.
Patient Consensus: Patients emphasize that stage 3 should not be automatically labeled inoperable. Success depends on the tumor board's ability to combine aggressive resection with advanced interventional radiology.